Related Experiment Video

Updated: May 22, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

[Molecular and genetic aspects of heart failure in diabetic patients]

E V Shliakhto

    Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
    |May 4, 2012
    PubMed

    Insights

    This study explores heart failure (HF) in diabetic patients, focusing on genetic factors and personalized treatments. It highlights molecular visualization and stem cell research for improved diagnosis and therapy.

    Area of Science:

    • Cardiology
    • Endocrinology
    • Genetics
    • Molecular Biology

    Context:

    • Diabetes mellitus (DM) significantly impacts heart failure (HF) development and clinical course.
    • Diabetic cardiopathy presents unique challenges in HF pathogenesis.
    • Understanding genetic predictors for DM and HF is crucial for risk stratification.

    Purpose:

    • To analyze the role of genetic predictors and personalized treatment strategies in managing HF in diabetic patients.
    • To explore the utility of molecular visualization in early diagnosis, monitoring, and assessing treatment efficacy.
    • To review advancements in understanding molecular and genetic mechanisms underlying HF in diabetic individuals.

    Summary:

    • Investigates the influence of diabetic cardiopathy on HF, emphasizing genetic predictors and personalized treatment approaches.
    • Examines stationary and dynamic genomics, including molecular visualization for early intervention and diagnosis of myocardial dysfunction.
    • Discusses targeted therapies, anti-ischemic protection, and the potential of metformin, alongside stem cell research for HF management.

    Impact:

    • Provides insights into optimizing HF treatment in diabetic patients through personalized medicine and advanced molecular technologies.
    • Highlights the potential of molecular visualization and genetic analysis for improved diagnostic and therapeutic strategies.
    • Identifies future research directions, including stem cell plasticity and gene expression in response to hyperglycemia.

    More Related Videos

    Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

    Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

    Published on: April 18, 2025

    Related Concept Videos

    Heart Failure II: Pathophysiology01:29

    Heart Failure II: Pathophysiology

    Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
    Heart Failure I: Introduction01:27

    Heart Failure I: Introduction

    Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
    Pathophysiology of Heart Failure01:17

    Pathophysiology of Heart Failure

    Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    Heart Failure IV: Classification and Diagnostic Evaluation01:30

    Heart Failure IV: Classification and Diagnostic Evaluation

    Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
    Heart Failure Drugs: Diuretics01:22

    Heart Failure Drugs: Diuretics

    Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...